Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00303758
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 202
Testing effectiveness (Phase 2)Looking for participantsNCT06789679
What this trial is testing

Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 128
Post-approval studies (Phase 4)UnknownNCT03401827
What this trial is testing

The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaChemotherapy Effect
Seoul National University Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT05472259
What this trial is testing

A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Belgian Group of Digestive Oncology 134
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750861
What this trial is testing

QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC

Who this might be right for
Pancreatic Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT00112580
What this trial is testing

MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Bristol-Myers Squibb 27
Testing effectiveness (Phase 2)Looking for participantsNCT06005493
What this trial is testing

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Gastric CancerGastro-esophageal Junction CancerPancreatic Ductal Adenocarcinoma+1 more
AstraZeneca 392
Early research (Phase 1)Ended earlyNCT06974734
What this trial is testing

A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

Who this might be right for
Carcinoma, Non Small Cell LungCarcinoma, Pancreatic DuctalMalignant Melanoma+1 more
Pfizer 8
Early research (Phase 1)Ended earlyNCT02376699
What this trial is testing

Safety Study of SEA-CD40 in Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Squamous CellHodgkin Disease+17 more
Seagen Inc. 159
Early research (Phase 1)Looking for participantsNCT07090499
What this trial is testing

Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more
Pfizer 540
Large-scale testing (Phase 3)Study completedNCT00844649
What this trial is testing

Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Metastatic Pancreatic Cancer
Celgene 861
Testing effectiveness (Phase 2)Study completedNCT00376948
What this trial is testing

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Barbara Ann Karmanos Cancer Institute 20
Early research (Phase 1)Not Yet RecruitingNCT07314385
What this trial is testing

NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma MetastaticLiver Metastasis
National Taiwan University Hospital 24
Early research (Phase 1)Study completedNCT00655655
What this trial is testing

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+17 more
Mayo Clinic 96
Testing effectiveness (Phase 2)UnknownNCT03666832
What this trial is testing

Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel

Who this might be right for
Metastatic Pancreatic Cancer
Joon Oh Park 36
Testing effectiveness (Phase 2)Study completedNCT03910387
What this trial is testing

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

Who this might be right for
Locally Advanced Unresectable Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Pancreatic Adenocarcinoma+2 more
Emory University 23
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00012220
What this trial is testing

Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 259
Testing effectiveness (Phase 2)Ended earlyNCT02626520
What this trial is testing

Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla

Who this might be right for
Ductal Adenocarcinoma of PancreasAdenocarcinoma of Ampulla
Essentia Health 11
Very early researchLooking for participantsNCT07089940
What this trial is testing

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+2 more
OHSU Knight Cancer Institute 12
Next Page